Cargando…

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

BACKGROUND: The use of maintenance medication in patients with chronic obstructive pulmonary disease (COPD) in real life is known to deviate from recommendations in guidelines, which are largely based on randomized controlled trials and selected populations. OBJECTIVES: We used the COSYCONET (COPD a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alter, Peter, Kahnert, Kathrin, Trudzinski, Franziska C., Bals, Robert, Watz, Henrik, Speicher, Tim, Söhler, Sandra, Welte, Tobias, Rabe, Klaus F., Wouters, Emiel F. M., Vogelmeier, Claus F., Jörres, Rudolf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631320/ https://www.ncbi.nlm.nih.gov/pubmed/37936408 http://dx.doi.org/10.1177/17534666231208584

Ejemplares similares

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2022)

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019)

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
por: Trudzinski, F. C., et al.
Publicado: (2020)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
por: Kahnert, Kathrin, et al.
Publicado: (2018)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
por: Trudzinski, Franziska C., et al.
Publicado: (2021)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality
por: Kahnert, Kathrin, et al.
Publicado: (2023)

Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
por: Kahnert, Kathrin, et al.
Publicado: (2022)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers
por: Alter, Peter, et al.
Publicado: (2022)

Consequences of chronic kidney disease in chronic obstructive pulmonary disease
por: Trudzinski, Franziska C., et al.
Publicado: (2019)

Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans
por: Kahnert, Kathrin, et al.
Publicado: (2018)

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
por: Waschki, Benjamin, et al.
Publicado: (2017)

COPD: the patient perspective
por: Jones, Paul W, et al.
Publicado: (2016)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients
por: Koczulla, Rembert, et al.
Publicado: (2009)

Personalized medicine for patients with COPD: where are we?
por: Franssen, Frits ME, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0b8urdm3fsm7ba9i5qqhnuchq2